BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Vitamin E
,
rs3825942
,
PRKCA
,
T cell differentiation
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TA1 receptor
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for TA1 receptor
Explore Curated Studies Results
Literature
Most Relevant Literature
Recognition of methamphetamine and other amines by trace amine receptor TAAR1.
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic…
Research progress of trace amine-associated receptor 1 signaling pathways].
Activation of trace amine-associated receptor 1 (TAAR1) transiently reduces alcohol drinking in soci…
TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjec…
A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Pal…
Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combi…
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thr…
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ